Bryan P. Yan and Guang-Ming Tan Pages 130 - 138 ( 9 )
Colchicine is a well-established drug approved by the Food and Drug Administration (FDA) for the prevention and treatment of gout. It possesses unique anti-inflammatory properties. Interests in the usage of colchicine in cardiovascular medicine have been rekindled recently with several large trials been carried out to investigate its efficacy in treatment of various cardiac conditions including pericarditis, postpericardiotomy syndrome, atrial fibrillation and coronary artery disease. In this review, the basic pharmacological properties of colchicine will be discussed, and the evidences of its benefits for different applications in cardiovascular medicine will be reviewed.
Colchicine, pericarditis, postpericardiotomy syndrome, atrial fibrillation, atherosclerosis.
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong